However, these studies have shown conflicting results in different cancer cell lines (29, 30), suggesting that there is a complex relationship between YTHDF1 and IFN-I in different contexts, which could be critical to the development of new therapeutic strategies that involve modulation of DCs. The gene discussed is YTHDF1; the disease is cancer.